FDA Takes New Steps to Increase the Safety of Laparoscopic Power Morcellators when used in Gynecologic SurgeriesFebruary 25, 2020
Med Man Expands Voluntary Nationwide Recall of Up2 and Bow & Arrow Due to Presence of Undeclared SildenafilFebruary 24, 2020
CDC Investigation Notice: Salmonella Outbreak Linked to Raw Turkey Products – Investigation Notice 2/15/19February 22, 2020
Moonstruck Chocolate Issues Allergy Alert on Undeclared Milk in 3.1 oz. Praline Pecan & Ginger Element Bar in Dark ChocolateFebruary 21, 2020
FDA Authorizes Marketing of the First Genetic Test to Aid in the Diagnosis of Fragile X SyndromeFebruary 21, 2020
Taro Pharmaceuticals U.S.A. Issues Voluntary Nationwide Recall of Phenytoin Oral Suspension USP, 125 mg/5ml Due to Possible Underdosing or OverdosingFebruary 21, 2020
FDA approves new treatment for hospital-acquired and ventilator-associated bacterial pneumoniaFebruary 21, 2020
Statement by FDA Commissioner Scott Gottlieb, M.D., on the agency’s ongoing work to forcefully address the opioid crisisFebruary 21, 2020
Companies cease sales of e-liquids with labeling or advertising that resembled kid-friendly foods following FDA, FTC warningsFebruary 21, 2020
FDA approves new treatment to prevent bleeding in certain patients with hemophilia AFebruary 21, 2020
Statement from FDA Commissioner Scott Gottlieb, M.D. on new steps to improve FDA review of shared Risk Evaluation and Mitigation Strategies to improve generic drug accessFebruary 21, 2020
Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA’s comprehensive new policy approach to facilitating the development of innovative regenerative medicine products to improve human healthFebruary 21, 2020
FDA unveils a streamlined path for the authorization of tumor profiling tests alongside its latest product actionFebruary 21, 2020
